Polymer-stabilized optical isotropic liquid crystal formulation and optical isotropic liquid crystal device
US-9222022-B2 · Dec 29, 2015 · US
US9776952B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9776952-B2 |
| Application number | US-201615016885-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 5, 2016 |
| Priority date | Mar 9, 2010 |
| Publication date | Oct 3, 2017 |
| Grant date | Oct 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays having a polymer-stabilized blue phase, and in LC media for LC displays of the PS or PSA type (“polymer sustained” or “polymer sustained alignment”), and to LC media and LC displays comprising these compounds.
Opening claim text (preview).
The invention claimed is: 1. Compounds of the formula I P a -(Sp a ) s1 -A 2 -CH 2 CH 2 -A 1 -CH 2 C 2 -A 3 -(Sp b ) s2 -P b I wherein the individual radicals have the following meaning P a P b each, independently of one another, denote a polymerisable group, Sp a , Sp b on each occurrence, identically or differently, denote a spacer group, s1, s2 each, independently of one another, denote 0 or 1, A 1 , A 2 , A 3 each, independently of one another, denote a radical selected from the following groups a) the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene and 4,4′-bicyclohexylene, wherein one or more non-adjacent CH 2 groups may be replaced by —O— and/or —S— and wherein, one or more H atoms may be replaced by F, b) the group consisting of 1,4-phenylene and 1,3-phenylene, wherein, one or two CH groups may be replaced by N and wherein, one or more H atoms may be replaced by L, c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobut-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may, in addition, be mono- or polysubstituted by L, d) the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo-[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, L on each occurrence, identically or differently, F denotes, Cl, CN, SCN, SF 5 or straight-chain or branched, in each case optionally fluorinated alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms, R 0 , R 00 each, independently of one another, denote H, F or straight-chain or branched alkyl having 1 to 12 C atoms, wherein, one or more H atoms may be replaced by F, M denotes —O—, —S—, —CH 2 —, —CHY— or —CY 1 Y 2 —, Y and Y 1 each, independently of one another, have one of the meanings indicated above for R 0 , or denote Cl or CN, and preferably denote H, F, Cl, CN, OCF 3 or CF 3 , and in which one or more of the radicals A 1 , A 2 and A 3 are selected from the group d) consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably in which one or more of the radicals A 1 , A 2 and A 3 are selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N. 2. Compounds of the formula IA G-O-(Sp a ) s1 -A 2 -CH 2 CH 2 -A 1 -CH 2 CH 2 -A 3 -(Sp b ) s2 -O-G′ IA wherein Sp a , Sp b , A 1 , A 2 , A 3 , s1 and s2 have the following meaning, Sp a , Sp b on each occurrence, identically or differently, denote a spacer group, s1, s2 each, independently of one another, denote 0 or 1, A 1 , A 2 , A 3 each, independently of one another, denote a radical selected from the following groups a) the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene and 4,4′-bicyclohexylene, wherein, one or more non-adjacent CH 2 groups may be replaced by —O— and/or —S— and wherein, one or more H atoms may be replaced by F, b) the group consisting of 1,4-phenylene and 1,3-phenylene, wherein, one or two CH groups may be replaced by N and wherein, one or more H atoms may be replaced by L, c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobut-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may, in addition, be mono- or polysubstituted by L, d) the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo-[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, and G and G′ each, independently of one another, denote an H atom or a protecting group. 3. The compounds of formula I of claim 1 wherein, A 1 is selected from a group consisting of: 4. The compounds of formula IA of claim 2 wherein, A 1 is selected from a group consisting of:
Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems · CPC title
Macromolecular compounds · CPC title
Ph-Ph-COO-Ph · CPC title
the heterocyclic ring being a six-membered ring · CPC title
containing esters · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.